U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from GEO Profiles

Items: 1 to 20 of 322

1.
CCDC6-RET fusion protein regulates Ras/MAPK signaling through the fusion- GRB2-SHC1 signal niche
Ting Qiu, Yichao Kong, Guifeng Wei, Kai Sun, Ruijie Wang, Yang Wang, Yiji Chen, Wenxin Wang, Yun Zhang, Caihong Jiang, Peiguo Yang, Tian Xie, Xiabin Chen
Proc Natl Acad Sci U S A. 2024 Jun 4; 121(23): e2322359121. Published online 2024 May 28. doi: 10.1073/pnas.2322359121
PMCID:
PMC11161787
AbstractArticlePDF–3.2M
2.
Analysis of DOK‐6 function in downstream signaling of RET in human neuroblastoma cells
Ai Kurotsuchi, Yoshiki Murakumo, Mayumi Jijiwa, Kei Kurokawa, Yasutomo Itoh, Yoshinori Kodama, Takuya Kato, Atsushi Enomoto, Naoya Asai, Hiroko Terasaki, Masahide Takahashi
Cancer Sci. 2010 May; 101(5): 1147–1155. Published online 2010 Feb 3. doi: 10.1111/j.1349-7006.2010.01520.x
PMCID:
PMC11159970
AbstractArticlePDF–646K
3.
Sprouty2 regulates growth and differentiation of human neuroblastoma cells through RET tyrosine kinase
Maki Ishida, Masatoshi Ichihara, Shinji Mii, Mayumi Jijiwa, Naoya Asai, Atsushi Enomoto, Takuya Kato, Ai Majima, Jiang Ping, Yoshiki Murakumo, Masahide Takahashi
Cancer Sci. 2007 Jun; 98(6): 815–821. Published online 2007 Mar 27. doi: 10.1111/j.1349-7006.2007.00457.x
PMCID:
PMC11158975
AbstractArticlePDF–275K
4.
Expression of Ret finger protein correlates with outcomes in endometrial cancer
Hirohisa Tsukamoto, Takuya Kato, Atsushi Enomoto, Nobuhisa Nakamura, Yohei Shimono, Mayumi Jijiwa, Naoya Asai, Yoshiki Murakumo, Kiyosumi Shibata, Fumitaka Kikkawa, Masahide Takahashi
Cancer Sci. 2009 Oct; 100(10): 1895–1901. Published online 2009 Jul 10. doi: 10.1111/j.1349-7006.2009.01278.x
PMCID:
PMC11158088
AbstractArticlePDF–3.4M
5.
RET protein promotes non‐adherent growth of NB‐39‐nu neuroblastoma cell line
Hitoyasu Futami, Ryuichi Sakai
Cancer Sci. 2009 Jun; 100(6): 1034–1039. Published online 2009 Feb 20. doi: 10.1111/j.1349-7006.2009.01143.x
PMCID:
PMC11158081
AbstractArticlePDF–1.9M
6.
Next-generation sequencing identified that RET variation associates with lymph node metastasis and the immune microenvironment in thyroid papillary carcinoma
Yongsheng Huang, Peiliang Lin, Jianwei Liao, Faya Liang, Ping Han, Sha Fu, Yuanling Jiang, Zhifan Yang, Ni Tan, Jinghua Huang, Renhui Chen, Nengtai Ouyang, Xiaoming Huang
BMC Endocr Disord. 2024; 24: 68. Published online 2024 May 11. doi: 10.1186/s12902-024-01586-5
PMCID:
PMC11088169
AbstractArticlePDF–8.5M
7.
Novel Human-Derived RET Fusion NSCLC Cell Lines Have Heterogeneous Responses to RET Inhibitors and Differential Regulation of Downstream Signaling
Laura Schubert, Anh T. Le, Adriana Estrada-Bernal, Andrea E. Doak, Minjae Yoo, Sarah E. Ferrara, Andrew Goodspeed, Fumi Kinose, Uwe Rix, Aik-Choon Tan, Robert C. Doebele
Mol Pharmacol. 2021 Jun; 99(6): 435–447. Published online 2021 Jun. doi: 10.1124/molpharm.120.000207
PMCID:
PMC11033948
AbstractArticlePDF–1.9M
8.
Aberrant SOX10 and RET expressions in patients with Hirschsprung disease
Gunadi, Verrell Christopher Amadeus, Fadila Dyah Trie Utami, Fiqih Vidiantoro Halim, Nabilah Anisa Novebri, Rahaditya Alrasyidi Hanggoro, Avinindita Nura Lestari, Kristy Iskandar, Andi Dwihantoro, Eko Purnomo
BMC Pediatr. 2024; 24: 189. Published online 2024 Mar 16. doi: 10.1186/s12887-024-04682-6
PMCID:
PMC10943800
AbstractArticlePDF–1.0M
9.
GDF-15 Inhibits ADP-Induced Human Platelet Aggregation through the GFRAL/RET Signaling Complex
Baikang Xie, Wenjing Tang, Shuang Wen, Fen Chen, Chao Yang, Min Wang, Yong Yang, Wei Liang
Biomolecules. 2024 Jan; 14(1): 38. Published online 2023 Dec 27. doi: 10.3390/biom14010038
PMCID:
PMC10813690
AbstractArticlePDF–2.4M
10.
Clinical characteristics of a large familial cohort with Medullary thyroid cancer and germline Cys618Arg RET mutation in an Israeli multicenter study
Rachel Chava Rosenblum, Dania Hirsch, Simona Grozinsky-Glasberg, Carlos Benbassat, Uri Yoel, Avraham Ishay, Sagit Zolotov, Gideon Bachar, Ehud Banne, Sigal Levy, Orit Twito
Front Endocrinol (Lausanne) 2023; 14: 1268193. Published online 2023 Oct 30. doi: 10.3389/fendo.2023.1268193
PMCID:
PMC10646927
AbstractArticlePDF–889K
11.
TMEM127 suppresses tumor development by promoting RET ubiquitination, positioning, and degradation
Qianjin Guo, Zi-Ming Cheng, Hector Gonzalez-Cantú, Matthew Rotondi, Gabriela Huelgas-Morales, Purushoth Ethiraj, Zhijun Qiu, Jonathan Lefkowitz, Wan Song, Bethany N. Landry, Hector Lopez, Cynthia M. Estrada-Zuniga, Shivi Goyal, Mohammad Aasif Khan, Timothy J. Walker, Exing Wang, Faqian Li, Yanli Ding, Lois M. Mulligan, Ricardo C.T. Aguiar, Patricia L.M. Dahia
Cell Rep. Author manuscript; available in PMC 2023 Nov 10.
Published in final edited form as: Cell Rep. 2023 Sep 26; 42(9): 113070. Published online 2023 Sep 1. doi: 10.1016/j.celrep.2023.113070
PMCID:
PMC10637630
AbstractArticlePDF–3.2M
12.
Extended RET Gene Analysis in Patients with Apparently Sporadic Medullary Thyroid Cancer: Clinical Benefits and Cost
Susan C. Lindsey, Ilda S. Kunii, Fausto Germano-Neto, Misaki Y. Sittoni, Cléber P. Camacho, Flávia O. F. Valente, Ji H. Yang, Priscila S. Signorini, Rosana Delcelo, Janete M. Cerutti, Rui M. B. Maciel, Magnus R. Dias-da-Silva
Horm Cancer. 2012 Aug; 3(4): 181–186. Published online 2012 May 31. doi: 10.1007/s12672-012-0109-7
PMCID:
PMC10358128
AbstractArticlePDF–402K
13.
Somatic Mutation Analysis of the SDHB, SDHC, SDHD, and RET Genes in the Clinical Assessment of Sporadic and Hereditary Pheochromocytoma
Alexander Weber, Michael M. Hoffmann, Hartmut P. H. Neumann, Zoran Erlic
Horm Cancer. 2012 Aug; 3(4): 187–192. Published online 2012 May 10. doi: 10.1007/s12672-012-0113-y
PMCID:
PMC10358101
AbstractArticlePDF–154K
14.
The Combination of RET, BRAF and Demographic Data Identifies Subsets of Patients with Aggressive Papillary Thyroid Cancer
Jose R. W. Martínez, Sergio Vargas-Salas, Soledad Urra Gamboa, Estefanía Muñoz, José Miguel Domínguez, Augusto León, Nicolás Droppelmann, Antonieta Solar, Mark Zafereo, F. Christopher Holsinger, Hernán E. González
Horm Cancer. 2019 Jun; 10(2-3): 97–106. Published online 2019 Mar 22. doi: 10.1007/s12672-019-0359-8
PMCID:
PMC10355709
AbstractArticlePDF–571K
15.
High Expression of the RET Receptor Tyrosine Kinase and Its Ligand GDNF Identifies a High-Risk Subset of Estrogen Receptor Positive Breast Cancer
Rasha T. Kakati, Hyunsoo Kim, Austin Whitman, Philip M. Spanheimer
Breast Cancer Res Treat. Author manuscript; available in PMC 2023 Jun 1.
Published in final edited form as: Breast Cancer Res Treat. 2023 Jun; 199(3): 589–601. Published online 2023 Apr 15. doi: 10.1007/s10549-023-06937-9
PMCID:
PMC10182256
AbstractArticlePDF–1.5M
16.
RET rearrangements are relevant to histopathologic subtypes and clinicopathological features in Thai papillary thyroid carcinoma patients
Thitima Khonrak, Sasithorn Watcharadetwittaya, Yaovalux Chamgramol, Piyapharom Intarawichian, Raksawan Deenonpoe
Pathol Oncol Res. 2023; 29: 1611138. Published online 2023 Apr 28. doi: 10.3389/pore.2023.1611138
PMCID:
PMC10175595
AbstractArticlePDF–1.5M
17.
RET Fusion-Positive Non-small Cell Lung Cancer: The Evolving Treatment Landscape
Silvia Novello, Raffaele Califano, Niels Reinmuth, Antonella Tamma, Tarun Puri
Oncologist. 2023 May; 28(5): 402–413. Published online 2023 Feb 23. doi: 10.1093/oncolo/oyac264
PMCID:
PMC10166168
AbstractArticlePDF–1.0M
18.
RET aberrant cancers and RET inhibitor therapies: Current state-of-the-art and future perspectives
Alfredo Addeo, Ernesto Miranda-Morales, Petra den Hollander, Alex Friedlaender, Herman O. Sintim, Jie Wu, Sendurai A. Mani, Vivek Subbiah
Pharmacol Ther. Author manuscript; available in PMC 2024 Feb 1.
Published in final edited form as: Pharmacol Ther. 2023 Feb; 242: 108344. Published online 2023 Jan 9. doi: 10.1016/j.pharmthera.2023.108344
PMCID:
PMC10141525
AbstractArticlePDF–959K
19.
Successful combination of selpercatinib and radioiodine after pretherapeutic dose estimation in RET-altered thyroid carcinoma
Rudolf A. Werner, Cyrus Sayehli, Heribert Hänscheid, Takahiro Higuchi, Sebastian E. Serfling, Martin Fassnacht, Maria-Elisabeth Goebeler, Andreas K. Buck, Matthias Kroiss
Eur J Nucl Med Mol Imaging. 2023; 50(6): 1833–1834. Published online 2022 Dec 16. doi: 10.1007/s00259-022-06061-8
PMCID:
PMC10119197
ArticlePDF–580K
20.
Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity
Martin Golkowski, Andrea Lius, Tanmay Sapre, Ho-Tak Lau, Taylor Moreno, Dustin J. Maly, Shao-En Ong
Mol Cell. Author manuscript; available in PMC 2023 Apr 4.
Published in final edited form as: Mol Cell. 2023 Mar 2; 83(5): 803–818.e8. Published online 2023 Feb 2. doi: 10.1016/j.molcel.2023.01.015
PMCID:
PMC10072906
AbstractArticlePDF–4.2M

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center